[go: up one dir, main page]

AU2001286116A1 - Reducing the content of particular cell types in a biological sample - Google Patents

Reducing the content of particular cell types in a biological sample

Info

Publication number
AU2001286116A1
AU2001286116A1 AU2001286116A AU8611601A AU2001286116A1 AU 2001286116 A1 AU2001286116 A1 AU 2001286116A1 AU 2001286116 A AU2001286116 A AU 2001286116A AU 8611601 A AU8611601 A AU 8611601A AU 2001286116 A1 AU2001286116 A1 AU 2001286116A1
Authority
AU
Australia
Prior art keywords
reducing
content
biological sample
cell types
particular cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001286116A
Inventor
Arezki Mahiout
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allied Therapeutics Ltd
Original Assignee
Allied Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allied Therapeutics Ltd filed Critical Allied Therapeutics Ltd
Publication of AU2001286116A1 publication Critical patent/AU2001286116A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3679—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by absorption
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
    • A61M1/3493—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate using treatment agents in suspension
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/0043—Catheters; Hollow probes characterised by structural features
    • A61M2025/0056—Catheters; Hollow probes characterised by structural features provided with an antibacterial agent, e.g. by coating, residing in the polymer matrix or releasing an agent out of a reservoir

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Vascular Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Obesity (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
AU2001286116A 2000-09-15 2001-09-14 Reducing the content of particular cell types in a biological sample Abandoned AU2001286116A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0022748.8A GB0022748D0 (en) 2000-09-15 2000-09-15 Reducing the content of cells in a biological sample
GB0022748.8 2000-09-15
PCT/GB2001/004126 WO2002024307A2 (en) 2000-09-15 2001-09-14 Reducing the content of particular cell types in a biological sample

Publications (1)

Publication Number Publication Date
AU2001286116A1 true AU2001286116A1 (en) 2002-04-02

Family

ID=9899579

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001286116A Abandoned AU2001286116A1 (en) 2000-09-15 2001-09-14 Reducing the content of particular cell types in a biological sample

Country Status (3)

Country Link
AU (1) AU2001286116A1 (en)
GB (1) GB0022748D0 (en)
WO (1) WO2002024307A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080254551A1 (en) * 2004-12-30 2008-10-16 Achsel Tilmann Immunoprecipitaion-Based Method to Purify and Characterise Biological Macromolecular Complexes
EP2021025B1 (en) * 2006-05-12 2016-08-17 ITH Immune Therapy Holdings AB Method and means for treating inflammatory bowel disease
DE102008045127A1 (en) * 2008-09-01 2010-03-04 Heinrich, Hans-Werner, Prof. Dr. Filter system for extracorporeal depletion of activated polymorphonuclear granulocytes (polymorphonuclear leukocytes PMNs)
WO2010029317A2 (en) 2008-09-10 2010-03-18 Ibd Column Therapies International Ab Treating inflammatory conditions
CA2776613A1 (en) 2009-10-07 2011-04-14 University Of Pittsburgh - Of The Commonwealth System Of Higher Educatio N Devices, systems and methods for cell modification
GB2479536A (en) * 2010-04-12 2011-10-19 Jon Lacy-Colson Blood filtration device for removing tumour cells

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9965A (en) 1853-08-23 Jonathan foreman
JPS61134325A (en) 1984-12-04 1986-06-21 Teijin Ltd Expression of hybrid antibody gene
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
DE69119683T2 (en) 1990-07-27 1996-10-02 Pall Corp Leukocyte removal filter and method of use
US5460945A (en) * 1991-05-30 1995-10-24 Center For Blood Research, Inc. Device and method for analysis of blood components and identifying inhibitors and promoters of the inflammatory response
AU2797892A (en) * 1991-10-03 1993-05-03 Center For Blood Research, The (plasmodium falciparum)-infected erythrocytes binding to icam-1 and cd36
EP0672142B1 (en) 1992-12-04 2001-02-28 Medical Research Council Multivalent and multispecific binding proteins, their manufacture and use
DE69635205T2 (en) 1995-07-10 2006-01-26 Asahi Medical Co. Ltd. EXTRACORPORAL BLOOD CIRCUIT FOR THE HEALING OF INFLAMMATORY DISEASES

Also Published As

Publication number Publication date
WO2002024307A2 (en) 2002-03-28
GB0022748D0 (en) 2000-11-01
WO2002024307A3 (en) 2003-10-16

Similar Documents

Publication Publication Date Title
AU2001253077A1 (en) Electrochemical cell and assembly for same
AU2001292657A1 (en) Sensor for chemical and biological materials
AU2001273730A1 (en) Sample for simultaneously conducting electro-chemical and topographic near-fieldmicroscopy
AU2001213236A1 (en) Mini-cyclone biocollector and concentrator
AU2323399A (en) Method and compositions for detecting luciferase in biological samples
AU2001250036A1 (en) Microdroplet cell culture technique
AU2001235452A1 (en) Cell culture media
AU2001296903A1 (en) Fuel cell using oxygen carrying liquid
AU2001229770A1 (en) Improved research and development process
AUPQ520600A0 (en) Improvements in electrolysis cells
AU2001267724A1 (en) Electrochemical cell
AU2001286116A1 (en) Reducing the content of particular cell types in a biological sample
AU6491699A (en) Biosensor cell device and its use
AU2001270478A1 (en) Gene expression in biological conditions
AU2002232032A1 (en) Electrochemical cells and their packaging
AU4474401A (en) Fuel for use in fuel cell
AU2001269081A1 (en) Electrochemical cells
AU3386401A (en) Fluid sample receptacle
AU4771600A (en) Cells, culture methods and their uses
AU2001258819A1 (en) Kit for assaying saccharified protein
AU2001286053A1 (en) Cell assays
AU2002212215A1 (en) Method and sampling kit for analysing material containing nucleic acid
AU2001254976A1 (en) Electrochemical methods and cells
AU2002214307A1 (en) T cell line and use thereof
AU2002217643A1 (en) Electrochemical analysis method